Share this post:
Case Studies
![](https://ala.associates/wp-content/uploads/2022/03/Logo-SeaBeLife.jpg)
Ongoing PR to Sustain market visibility
After receiving €1.37M from Bpifrance, SeaBeLife, a French biotech company developing drug candidates intended to block cell necrosis, wished to increase its visibility and gain market recognition.
To download documents, you can right-click on the links above and chose « Save link as… »